CQ's Carey Discusses Generic Drug Market Entry, Movements To Cover Uninsured U.S. Residents, Genetic Discrimination
Thu, 25 Jan 2007 01:00 AM EST
... Mary Agnes Carey, associate editor of CQ HealthBeat, examines pharmaceutical companies' deals to delay sales of generic prescription drugs, initiatives to expand health insurance coverage and legislation that would ban genetic discrimination in this week's "Health on the Hill from kaisernetwork.org and CQ." According to Carey, Senate Judiciary Committee Chair Patrick Leahy (D-Vt. [click link for full article] ...
Related Topics
- Discrimination
- Genetic Disorders
- Genetics/genetic Discrimination
- Genetic Counseling
- Research
- Confined Spaces
- Data & Statistics
- Rofecoxib Oral Suspension
- Periodic Limb Movements in Sleep
- Drug Safety
- Prescription Drugs
- Workplace
- Genetics
- Cerivastatin - Withdrawn From The Market
- Drug Side Effects
- Genetic Testing
- Drug Abuse
- Drug Information
- Birth Defects
- Prescription Drug Abuse

Not Signed In -


